NO2731622T3 - - Google Patents
Info
- Publication number
- NO2731622T3 NO2731622T3 NO12744086A NO12744086A NO2731622T3 NO 2731622 T3 NO2731622 T3 NO 2731622T3 NO 12744086 A NO12744086 A NO 12744086A NO 12744086 A NO12744086 A NO 12744086A NO 2731622 T3 NO2731622 T3 NO 2731622T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Nanotechnology (AREA)
- Biomedical Technology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1156398A FR2977800B1 (fr) | 2011-07-13 | 2011-07-13 | Composition vaccinale avec des nanoparticules d'hydroxyde d'aluminium |
| PCT/FR2012/051648 WO2013007956A1 (fr) | 2011-07-13 | 2012-07-12 | Composition vaccinale avec des nanoparticules d'hydroxyde d'aluminium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2731622T3 true NO2731622T3 (enExample) | 2018-03-10 |
Family
ID=46639612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO12744086A NO2731622T3 (enExample) | 2011-07-13 | 2012-07-12 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9770505B2 (enExample) |
| EP (1) | EP2731622B1 (enExample) |
| JP (1) | JP6111245B2 (enExample) |
| CN (1) | CN103826658A (enExample) |
| CA (1) | CA2838817A1 (enExample) |
| ES (1) | ES2650740T3 (enExample) |
| FR (1) | FR2977800B1 (enExample) |
| NO (1) | NO2731622T3 (enExample) |
| WO (1) | WO2013007956A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107496915B (zh) * | 2015-01-23 | 2025-02-25 | 四川大学 | 一种基于氢氧化铝纳米粒的疫苗载体 |
| CN106177939B (zh) * | 2015-06-01 | 2021-01-19 | 普莱柯生物工程股份有限公司 | 一种疫苗用佐剂及其应用 |
| CN106421775B (zh) * | 2015-08-12 | 2020-12-01 | 普莱柯生物工程股份有限公司 | 一种疫苗用佐剂及含该佐剂的疫苗组合物和其应用 |
| WO2017053594A1 (en) * | 2015-09-23 | 2017-03-30 | The Regents Of The University Of California | Compositions and methods of using the same for decontamination of skin |
| CN107041952B (zh) * | 2016-02-05 | 2020-11-10 | 中国人民解放军军事医学科学院微生物流行病研究所 | 表面修饰有氧化铝的疫苗及其制备方法和疫苗组合物 |
| EP3463300A1 (en) * | 2016-06-01 | 2019-04-10 | Infectious Disease Research Institute | Nanoalum particles containing a sizing agent |
| CN113666404B (zh) * | 2021-09-23 | 2023-07-28 | 北京智飞绿竹生物制药有限公司 | 一种适合规模化生产的高浓度纳米级氢氧化铝佐剂配制方法 |
| CN118846101A (zh) * | 2022-02-18 | 2024-10-29 | 广州瑞贝斯药业有限公司 | 一种铝纳米晶复合免疫药物及其制备方法和应用 |
| GB202215072D0 (en) * | 2022-10-13 | 2022-11-30 | Glaxosmithkline Biologicals Sa | Process for production of aluminium hydroxide particles |
| CN115944723A (zh) * | 2022-12-22 | 2023-04-11 | 中国人民解放军陆军军医大学 | 基于纳米铝盐与纳米乳的复合物在制备疫苗佐剂中的应用及其产品 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK143689C (da) * | 1975-03-20 | 1982-03-15 | J Kreuter | Fremgangsmaade til fremstilling af en adsorberet vaccine |
| US4836948A (en) * | 1987-12-30 | 1989-06-06 | Lever Brothers Company | Viscoelastic gel detergent compositions |
| DE69332031T2 (de) * | 1993-01-08 | 2002-12-19 | Csl Ltd., Parkville | Impfstoffpräparate |
| ES2284287T3 (es) * | 1998-10-16 | 2007-11-01 | Glaxosmithkline Biologicals S.A. | Sistemas adyuvantes y vacunas. |
| GB0118249D0 (en) * | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
| CN101325967A (zh) * | 2005-11-04 | 2008-12-17 | 诺华疫苗和诊断有限公司 | 水包油乳液佐剂含量降低的流感疫苗 |
| ES2377884T3 (es) * | 2005-11-04 | 2012-04-02 | Novartis Vaccines And Diagnostics S.R.L. | Vacunas contra la gripe que incluyen combinaciones de adyuvantes particulados e inmunopotenciadores |
| JP5650406B2 (ja) * | 2007-03-07 | 2015-01-07 | ユーティーアイ リミテッド パートナーシップ | 自己免疫状態の予防および治療のための組成物および方法 |
| JP2010534622A (ja) * | 2007-07-26 | 2010-11-11 | サノフィ パストゥール リミテッド | 抗原−アジュバント組成物および方法 |
| EP2419129A2 (en) * | 2009-04-14 | 2012-02-22 | Novartis AG | Compositions for immunising against staphylococcus aerus |
-
2011
- 2011-07-13 FR FR1156398A patent/FR2977800B1/fr not_active Expired - Fee Related
-
2012
- 2012-07-12 CA CA2838817A patent/CA2838817A1/fr not_active Abandoned
- 2012-07-12 WO PCT/FR2012/051648 patent/WO2013007956A1/fr not_active Ceased
- 2012-07-12 ES ES12744086.5T patent/ES2650740T3/es active Active
- 2012-07-12 US US14/131,616 patent/US9770505B2/en not_active Expired - Fee Related
- 2012-07-12 EP EP12744086.5A patent/EP2731622B1/fr not_active Not-in-force
- 2012-07-12 JP JP2014519611A patent/JP6111245B2/ja not_active Expired - Fee Related
- 2012-07-12 NO NO12744086A patent/NO2731622T3/no unknown
- 2012-07-12 CN CN201280034602.8A patent/CN103826658A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2731622A1 (fr) | 2014-05-21 |
| FR2977800A1 (fr) | 2013-01-18 |
| FR2977800B1 (fr) | 2014-03-14 |
| JP2014520836A (ja) | 2014-08-25 |
| WO2013007956A1 (fr) | 2013-01-17 |
| JP6111245B2 (ja) | 2017-04-05 |
| US20140234422A1 (en) | 2014-08-21 |
| US9770505B2 (en) | 2017-09-26 |
| EP2731622B1 (fr) | 2017-10-11 |
| ES2650740T3 (es) | 2018-01-22 |
| CA2838817A1 (fr) | 2013-01-17 |
| CN103826658A (zh) | 2014-05-28 |